TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: pH holding time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: sensory perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longer weekend sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: earlier sleep timing
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Levels of miR-191-5p
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Canonical pathways associated with cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Resolution of at least one DRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ABC-I scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD increases at the lumbar spine and total hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in BTMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of the regimens
Endpoint domain: Adverse events/effects
Primary endpoint: willingness to take medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perceived personal control over symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: acceptance of medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adjusted episode rate of incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receptive vocabulary scores at 3 years of age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Verbal aspects of cognition at 3 years of age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: bother caused by symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical global impression of improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADHD‐IV scales improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder Pain and Disability Index total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of acute non-contact leg injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Extent of adhesive encapsulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of dentin demineralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Role of advance directives in decision making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensory-somatomotor brain-wide connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Thalamic connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glycaemic control (A1C levels)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CAMI scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in PKS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall survival (OSran)
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from treatment failure (FFTFran)
Endpoint domain: Mortality/survival
Primary endpoint: stable disease at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life maintained during therapy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean follow-up serum potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LKSS score post-treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for re-treatment within 1-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: specific IgG4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Comfort using MEDLINE
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort using the Cochrane Library
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utilization of searching techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pain onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean best-corrected visual acuity (BCVA) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in surface area affected by AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum drug-bound IL-18 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Inhibition of IL-18-induced IFN-γ production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Confidence in trainees
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: RFS (Relapse-Free Survival)
Endpoint domain: Mortality/survival
Primary endpoint: Serum C-reactive protein (CRP) level recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation of POC A1C values with laboratory A1C values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attack frequency of Raynaud's phenomenon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attack severity of Raynaud's phenomenon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thermographic response to cold challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of onset of emesis or rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Completion of study without additional antiemetic therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: frequency of headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of headaches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction of cluster headache attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean AUC from 0 to 90 minutes for CGRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bone Mineral Density (BMD) reduction at the spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone Mineral Density (BMD) reduction at the hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression at 6 months after CS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incremental area under the curve (IAUC) of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: IAUC of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulinaemic index (II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in problems among families
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Strokes or systemic emboli
Endpoint domain: Mortality/survival
Primary endpoint: Change in Intolerance of Uncertainty (IU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced depressive symptom levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with plasma HIV-1 RNA <40 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of child custody
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Knowledge of GDM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Family and general functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: LD flux values during rest and after ACh application
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Healthcare costs per 1000 hours of exposure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of median RUV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rebleeding within 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events including encephalopathy
Endpoint domain: Adverse events/effects
Primary endpoint: Severe postoperative nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Sedation after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: HOMA insulin resistance index reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of major peri-procedural bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of H. pylori in nasal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target MAP achievement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global smoothness in MAP control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amputation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of successful device placement and defect closure without major complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Identification of urinary podocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of complete responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tubule occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to transfer for DCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Eosinophil counts in bronchoalveolar lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte numbers in bronchoalveolar lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Eosinophil cationic protein levels in bronchoalveolar lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: lean mass accretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QFT-GIT sensitivity for active TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: QFT-GIT specificity for active TB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rates of conversion and reversion at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: inhibitory control impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor coordination impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived ability to manage back pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: passive torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal joint angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking skills improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swimming skills improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Ki-67
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discriminative mass/charge values as biomarkers for RA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: osteocalcin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: average MMSE score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of postoperative cognitive dysfunction (POCD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of bacterial vaginosis (BV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of chest pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SVEC burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: m-WCAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PTPes(insp)/breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: total intention score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total intentional solutions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of intentional solutions on cloth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of intentional solutions on cover
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days to therapeutic trough concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: MJD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: PFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ATRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Confirmed OSA diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total cholesterol/high-density lipoprotein cholesterol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: apolipoprotein B/apolipoprotein A-I ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean TRUS volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean individual change in serum creatinine at 48 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Anterior displacement values in ACL injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TFI scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in total atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decrease in lipid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvement in EPA/AA ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Surgical performance evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: %HbA1c changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: physical symptom distress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Cucumber intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wrist extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity of LER strip for diagnosing SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of LER strip for diagnosing SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of using emergency contraception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of having unprotected sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum retinol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of presymptomatic AD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of adverse health effects
Endpoint domain: Adverse events/effects
Primary endpoint: risk of heart failure/death
Endpoint domain: Mortality/survival
Primary endpoint: Continued abstinence at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: U‐AQP2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: FENa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Treatment Hall percentage attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recurrence rate of LARTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Castelli index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: knee joint comfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: subclinical infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: days spent in the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: earlier walking start
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: functional result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in total lesion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levodopa area under the plasma concentration time curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Development Index (MDI) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevention of mental retardation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EIFEL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall patient evaluation improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of dental contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CWLE duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year regret costs reduction
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of regrowing hair follicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median tumour progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: grade 3/4 nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Days of TS and GIr
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: GI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of inadequate BIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean absolute deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median absolute performance error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proliferation activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: invasion ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at different levels of hospitals (primary, secondary, tertiary)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alveolar clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in HbA1c from baseline to week 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fasting plasma glucose from baseline to week 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Asymmetric dimethylarginin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Microvascular response to flicker light
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 4-week continuous abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: continuous abstinence from weeks 9-24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease in end tidal carbon dioxide pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease in spontaneous respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: thirst sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes